Summary
The quality screen selects 50 U.S. non-financial small-cap stocks with a market capitalisation of at least $50 million, ranked by return on equity (ROE) from point-in-time SEC filings. Each stock starts at an equal 2% weight at the semi-annual March and September rebalances.
From March 2006 to September 2026, annualised returns rose from 8.4% in 2006–2015 to 18.8% in 2016–2026, averaging 13.6% a year overall with 26.8% annualised volatility (a 0.55 Sharpe ratio, matching the Fama–French Market benchmark while outperforming its 11.2% CAGR).
The Fama–French five-factor model explained 83% of daily return variation (R² = 0.83) over the full 20-year window and identified +5.2% annualised alpha (p = 0.037).
1. Performance Through Stress: 2006–2015 (GFC & Recovery)
The 2008–2009 credit freeze tested whether high-ROE small-caps held up better than deep-value peers. Switch the interactive chart above to 2006–2015 and toggle Drawdown to compare the path.
- Drawdown: The portfolio fell 62.4% from July 2007 to March 2009, versus 54.6% for the market benchmark (and milder than small-cap value’s
-67.4%). - Recovery: NAV regained its prior peak in 11.8 months from the March 2009 trough, versus 35.7 months for the market benchmark.
- Factors: Market (
+1.05) and size (+0.81) drove most of the variance (R² = 0.90), with near-zero value exposure (-0.08). - Returns: The portfolio returned 8.4% a year with 26.7% annualised volatility (Sharpe
0.40vs.0.38market) and lost money in 7 of 20 half-year periods.
2. Modern Market Regime: 2016–2026 (COVID-19 & Rate Cycles)
In the second decade, small-cap quality compounded substantially faster while keeping volatility steady at 26.9%.
- Drawdown: The portfolio fell 46.0% into the March 2020 trough, versus 34.2% for the market benchmark.
- Recovery: Portfolio NAV regained its prior high in 2.6 months, outpacing the market’s 4.4-month recovery.
- Factors: Market (
+0.98) and size (+0.96) remained the primary exposures (R² = 0.77), with +7.6% annualised alpha (p = 0.053). - Returns: The portfolio returned 18.8% a year with 26.9% annualised volatility (Sharpe
0.69vs.0.74market), posting losses in 7 of 22 half-year periods.
Full-Sample & Regime Summary
| Metric | Full Sample (2006–2026) | 2006–2015 Regime | 2016–2026 Regime |
|---|---|---|---|
| Annualised Return | 13.6% (11.2% Mkt) | 8.4% (7.2% Mkt) | 18.8% (15.2% Mkt) |
| Annualised Volatility | 26.8% (19.6% Mkt) | 26.7% (21.0% Mkt) | 26.9% (18.3% Mkt) |
| Sharpe Ratio | 0.55 (0.55 Mkt) | 0.40 (0.38 Mkt) | 0.69 (0.74 Mkt) |
| Max Drawdown | -62.4% (-54.6% Mkt) | -62.4% (-54.6% Mkt) | -46.0% (-34.2% Mkt) |
| Post-Trough Recovery | 11.8 months (35.7m Mkt) | 11.8 months | 2.6 months (4.4m Mkt) |
| Negative Half-Year Periods | 14 / 42 | 7 / 20 | 7 / 22 |
| Fama–French 5-Factor R² | 0.83 | 0.90 | 0.77 |
| FF5 Annualised Alpha | +5.2% (p = 0.037) | +2.2% (p = 0.428) | +7.6% (p = 0.053) |
Conclusion
Small-cap quality dampened volatility by roughly four percentage points relative to US Small-Cap Value 50 while still generating statistically significant positive alpha over the 20-year window. As seen in US Mid-Cap Quality 50, that profitability edge eroded sharply once the universe floor moved up to $500 million.